A PHASE II, MULTICENTER, OPEN-LABEL, LONG-TERM STUDY OF THE SAFETY, TOLERABILITY, AND EFFICACY OF INTRAVENOUS NATALIZUMAB IN SUBJECTS WITH RHEUMATOID ARTHRITIS WHO HAVE PREVIOUSLY PARTICIPATED IN STUDY ELN100226-RA201: